000963 華東醫藥
按盤價 
35.180 +1.090 (+3.197%)
35.180 +1.090 (+3.197%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.966 | 14.265 | 15.925 | 14.328 | 14.217 |
| 總資產報酬率 ROA (%) | 2.539 | 8.878 | 9.839 | 8.775 | 8.590 |
| 投入資產回報率 ROIC (%) | 3.254 | 11.571 | 13.047 | 11.916 | 11.856 | 邊際利潤分析 |
| 銷售毛利率 (%) | 33.943 | 32.359 | 33.211 | 32.400 | 31.903 |
| 營業利潤率 (%) | 10.730 | 9.419 | 10.320 | 8.500 | 8.117 |
| 息稅前利潤/營業總收入 (%) | 10.618 | 9.253 | 10.318 | 8.658 | 8.245 |
| 淨利潤/營業總收入 (%) | 8.916 | 7.821 | 8.338 | 7.007 | 6.715 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.864 | 105.145 | 102.585 | 102.189 | 103.790 |
| 價值變動淨收益/利潤總額(%) | -1.871 | -3.432 | -3.003 | -6.736 | -3.731 |
| 營業外收支淨額/利潤總額(%) | -0.657 | -2.276 | -0.540 | 0.377 | -1.001 | 償債能力分析 |
| 流動比率 (X) | 1.673 | 1.622 | 1.526 | 1.712 | 1.730 |
| 速動比率 (X) | 1.264 | 1.199 | 1.180 | 1.315 | 1.288 |
| 資產負債率 (%) | 34.630 | 35.522 | 37.792 | 35.593 | 38.522 |
| 帶息債務/全部投入資本 (%) | 16.290 | 16.180 | 18.143 | 13.552 | 14.209 |
| 股東權益/帶息債務 (%) | 503.412 | 507.340 | 441.461 | 620.086 | 578.494 |
| 股東權益/負債合計 (%) | 186.197 | 178.923 | 161.087 | 176.469 | 154.613 |
| 利息保障倍數 (X) | -251.300 | 214.948 | 194.199 | 68.709 | 39.733 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 80.726 | 71.860 | 68.213 | 64.930 | 65.048 |
| 存貨周轉天數 (天) | 66.173 | 62.923 | 58.309 | 57.587 | 59.364 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
